Inverse probability of treatment-weighted analysis; Clopidogrel (n=534) Aspirin (n=1,285) p value Standardized difference Clopidogrel (n=533) et al
Aspirin has been known for years to reduce recurrent strokes after the initial episode
This editorial refers to ‘Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial
Genetic and non-genetic factors affecting the response to clopidogrel therapy
In OPTIMIZE (Optimized Duration of Clopidogrel Therapy Following Treatment With the Zotarolimus-Eluting Stent in Real-World Clinical Practice), STEMI patients were excluded
The panel was confident that DAPT given for 10-21 days compared with 22-90 days results in: Antithrombotic therapy is the cornerstone of pharmacological treatment aimed at preventing ischemic events following PCI
Triple therapy (TT) refers to the concurrent use of an oral anticoagulant (OAC), such as warfarin, and dual antiplatelet therapy (DAPT), such as acetylsalicylic acid (ASA) plus clopidogrel
Patients selected for percutaneous coronary intervention (PCI), with the placement of a coronary stent, will require dual antiplatelet therapy with aspirin and either cangrelor, clopidogrel, prasugrel, or ticagrelor
topiramate
2
The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel
The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remains unsettled
52 The Atrial Fibrillation and Ischemic Events with Rivaroxaban in Patients with Stable Coronary Artery Disease